Health Technology Collaboration | Tissuepathology.com

Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers

Erica Goodpaster — Mon, 06 Jul 2026 12:12:01 +0000

CHICAGO, June 25, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a research collaboration with Angiosarcoma Awareness, Inc. to accelerate data-driven research in angiosarcoma, one of the rarest and most aggressive cancers. Angiosarcoma is a rare malignant tumor that starts […]

The post Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers first appeared on Tissuepathology.com.

Bioptimus: Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme

Erica Goodpaster — Tue, 30 Jun 2026 13:05:31 +0000

Partnership grants Bioptimus access to unique European cohort of data Fédération Francophone de Cancérologie Digestive to share high quality clinical data of 3,000 GI cancer patients Significant progress in the STELA programme to build the largest global AI biology model More partnership announcements in Bioptimus’s pipeline Tuesday June 27th 2026 – Paris, France: Bioptimus has […]

The post Bioptimus: Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme first appeared on Tissuepathology.com.

Versant Diagnostics Expands Collaboration with Leica Biosystems as PRW Laboratories Becomes First to Deploy Aperio GT Elite Solution

Erica Goodpaster — Wed, 24 Jun 2026 13:08:58 +0000

Versant Diagnostics and Leica Biosystems: Milestone deployment reflects growing demand for high-throughput, AI-enabled digital pathology workflows VISTA, CA, June 24, 2026 – Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Versant Diagnostics, an independent physician services company actively engaged in next-generation digital pathology, announce an expanded collaboration […]

The post Versant Diagnostics Expands Collaboration with Leica Biosystems as PRW Laboratories Becomes First to Deploy Aperio GT Elite Solution first appeared on Tissuepathology.com.

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Erica Goodpaster — Fri, 19 Jun 2026 12:16:28 +0000

Charles River and Lilly Tune Lab: Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab was created to […]

The post Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise first appeared on Tissuepathology.com.

Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists

Erica Goodpaster — Thu, 18 Jun 2026 15:22:57 +0000

PHILADELPHIA — June 17, 2026 — Proscia® today introduced the Fifth Generation of its Concentriq®[1] platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to evidence-based program decisions. Proscia is trusted by diagnostic laboratories that manage 12 million patient cases annually, and 16 of the top 20 pharmaceutical companies. Pathology sits […]

The post Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists first appeared on Tissuepathology.com.

ASCO: Now and Then

Dr. Keith J. Kaplan — Thu, 11 Jun 2026 18:00:28 +0000

In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in downtown Chicago was $1000/month. I wasshort over $300 a […]

The post ASCO: Now and Then first appeared on Tissuepathology.com.